Werbung
Werbung
NRSN
NeuroSense Therapeutics Ltd. Ordinary Shares
1.06
USDGesponsert
+0.13
+13.54%
09. Jan., 15:43 UTC -5
Geschlossen
Nach-Markt
1.07
+0.01
+0.94%
NRSN Ergebnisberichte
Positives Überraschungsverhältnis
NRSN übertreffen die 5 der letzten 8Schätzungen.
63%
Nächster Bericht
Datum des nächsten Berichts
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/--
Implizierte Änderung von Q-- -1 (Revenue/ EPS)
--
/--
NeuroSense Therapeutics Ltd. Ordinary Shares earnings per share and revenue
On 05. Jan. 2026, NRSN reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -0.05 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference.
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were NeuroSense Therapeutics Ltd. Ordinary Shares's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, NeuroSense Therapeutics Ltd. Ordinary Shares reported EPS of --, missing estimates by --, and revenue of --, 0% as expectations.
How did the market react to NeuroSense Therapeutics Ltd. Ordinary Shares's Q3 2025 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is NeuroSense Therapeutics Ltd. Ordinary Shares expected to report next?
The next earning report is scheduled for --.
What are the forecasts for NeuroSense Therapeutics Ltd. Ordinary Shares's next earnings report?
Based on --
analysts, NeuroSense Therapeutics Ltd. Ordinary Shares is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung